Mangalam Drugs and Organics Ltd MANGALAM-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 9:27 AM IST
113.85quote price arrow up+5.00 (+4.59%)
Volume
27,234
52 week range
95.50 - 196.95
Loading...
  • Open110.20
  • Day High116.95
  • Day Low108.45
  • Prev Close108.85
  • 52 Week High196.95
  • 52 Week High Date07/27/21
  • 52 Week Low95.50
  • 52 Week Low Date03/31/22

Key Stats

  • Market Cap22.98M
  • Shares Out15.83M
  • 10 Day Average Volume14,778.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-12.39

KEY STATS

  • Open110.20
  • Day High116.95
  • Day Low108.45
  • Prev Close108.85
  • 52 Week High196.95
  • 52 Week High Date07/27/21
  • 52 Week Low95.50
  • 52 Week Low Date03/31/22
  • Market Cap22.98M
  • Shares Out15.83M
  • 10 Day Average Volume14,778.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-12.39

RATIOS/PROFITABILITY

  • EPS (TTM)9.55
  • P/E (TTM)11.92
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date12/21/2017
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest On Mangalam Drugs and Organics Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mangalam Drugs and Organics Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The Company handles marketing in both domestic and export markets. The Company is also engaged in the Fight Malaria program for the supply of anti-malarial APIs worldwide. Its API products include Acyclovir, Amodiaquine HCI, Artemether, Artesunate, Atazanavir Sulfate, Atorvastatin Calcium, Bisoprolol Fumarate and Furosemide. Its intermediates...
Govardhan Dhoot
Executive Chairman of the Board, Chief Executive Officer
Ajay Samant
Chief Financial Officer
Address
3Rd Floor
Rupam Building 239, P. D'mello Road
Mumbai
400001
India